Hologic President and CEO Steve MacMillan is stepping down after nearly 13 years, marking the end of an era for the medtech company. | Hologic President and CEO Steve MacMillan is stepping down after ...

Fortrea is expanding its capabilities with a suite of AI-powered technologies designed to automate workflows, streamline ...

Owlet is quickly rearranging its nest as Jonathan Harris has resigned, effective immediately, as president and CEO of the pediatric device company. | Owlet is quickly rearranging its nest as Jonathan ...

California-based medtech E2 (Endovascular Engineering) has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment. | California-based medtech E2 ...

Eli Lilly has handed AC Immune 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC ...

When a biopharma company known for its expertise in a specific domain turns to a collaborator to expand its capabilities in ...

Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...

Sanofi’s TSLP and IL-13 inhibitor has aced a pair of mid-stage studies for respiratory diseases, but missed on a phase 2 ...

While the opioid epidemic is one of the most urgent public health emergencies facing the U.S., new therapeutic approaches for treating the underlying substance use disorder have lagged far behind. | ...

Takeda has terminated a neuro partnership with Denali Therapeutics as the Japanese pharma undergoes a massive restructuring ...

AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI ...

Newly uncloaked Stipple Bio is connecting the dots toward multiple early-stage clinical studies for its lead precision ...